FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to diagnostic techniques for connective tissue dysplasia (CTD) and can be used in ophthalmology. The external inspection of the eye region is performed. If detecting a short palpebral fissure 26 to 23 mm, connective tissue dysplasia is diagnosed.
EFFECT: method allows improving accuracy of CTD diagnosing.
3 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING CONNECTIVE TISSUE DYSPLASIA | 1999 |
|
RU2157104C1 |
| DIAGNOSTIC METHOD FOR CONNECTIVE TISSUE DYSPLASIA | 2017 |
|
RU2665387C1 |
| METHOD OF DETECTING DYSPLASIA OF CONNECTIVE TISSUE IN CHILDREN | 2012 |
|
RU2493768C1 |
| METHOD OF EARLY DIAGNOSTICS OF LATENT ELONGATION OF QT INTERVAL IN PATIENTS WITH MINOR HEART ANOMALIES | 2012 |
|
RU2489084C1 |
| AGE-SPECIFIC DIAGNOSTIC TECHNIQUE FOR VARIOUS FORMS OF CONNECTIVE TISSUE DYSPLASIA SYNDROME | 2013 |
|
RU2543166C2 |
| METHOD FOR PREDICTION OF UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA IN PREGNANT WOMEN | 2013 |
|
RU2539996C2 |
| METHOD FOR PREDICTING RISK OF NON-HEREDITARY CONNECTIVE TISSUE DYSPLASIA IN CHILDREN | 2020 |
|
RU2755976C1 |
| METHOD FOR PREDICTION OF UNFAVOURABLE CLINICAL COURSE OF NONSPECIFIC VULVOVAGINITIS IN GIRLS | 2011 |
|
RU2482484C2 |
| METHOD FOR DIAGNOSTICS OF NON-DIFFERENTIAL CONNECTIVE TISSUE DYSPLASIA IN PREGNANT WOMEN | 2016 |
|
RU2639820C1 |
| METHOD FOR DETERMINING THE SEVERITY OF NON-HEREDITARY CONNECTIVE TISSUE DYSPLASIA IN CHILDREN | 2020 |
|
RU2765784C1 |
